Circulating Tumor Cells Reveal Early Predictors of Disease Progression in Patients with Stage III NSCLC Undergoing Chemoradiation and Immunotherapy

Using an ultrasensitive graphene oxide microfluidic chip nanotechnology built with graphene oxide sheets, researchers were able to demonstrate that circulating tumor cells could be specifically isolated and molecularly characterized to predict future progression in patients with stage III NSCLC.